Business
Consortium with OBD receives ?4m Horizon 2020 fund
Consortium with OBD receives ?4m Horizon 2020 fund.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n \nRNS Number : 0169B Oxford BioDynamics PLC 18 September 2018 \n\n18 September 2018\n \nOxford BioDynamics Plc\n(\"OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\n \nConsortium including Oxford BioDynamics receives €4 million Horizon 2020 award\n \n• Horizon 2020 is the largest European funding programme for research and innovation\n \n• The consortium brings together established leaders in theoretical and experimental epigenetic research to advance the use of predictive epigenetics into real world applications\n \n· OBD, as an industry partner, is well positioned to access commercial opportunities arising from successful new applications of the EpiSwitch™ technology\n \nOxford BioDynamics Plc is pleased to announce that it has been chosen as an industrial partner in a Horizon 2020 international research and innovation collaboration. The initiative on \"Predictive Epigenetics\" (PEP-NET), which has been granted €4 million, brings together an international consortium of 11 leading epigenetic research centres and five partner organisations* to develop practical translation of epigenetic regulation into therapeutically actionable outcomes.\n \nThe PEP-NET consortium comprises experimentalists and theoreticians whose goal is to develop a joint predictive modelling framework to further the understanding of fundamental epigenetic mechanisms. The outcome will present real world applications for the development of new technologies, and diagnostic and therapeutic tools to benefit patients. \n \nThis will be an important opportunity for OBD to increase utilisation of its EpiSwitch™ platform and further develop its technology globally, while helping to improve understanding of epigenetic controls and mechanisms. As an industry partner in this initiative, all parties will have access to OBD's intellectual property for research purposes only.\n \nConsortium member Professor Leonie Ringrose, Institute of Biology, Humboldt University, Berlin, commented:\n \n\"Epigenetic mechanisms are profoundly implicated in human health and disease. Despite the availability of large amounts of molecular data sets today, the field is still far from a satisfactory mechanistic understanding ...